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S U M M A R Y
We describe the ﬁrst reported case of gonococcal septic shock with associated acute respiratory distress
syndrome and multisystem organ failure, in which the patient made a full recovery, and add to the
paucity of descriptive literature on gonococcal sepsis. The case was a 36-year-old previously healthy
Aboriginal female from northern Canada. Treatment included ﬂuid resuscitation, vasoactive drugs,
mechanical ventilation, antimicrobial therapy, corticosteroid replacement, activated protein C, and
general supportive care. In addition to being the ﬁrst reported case of gonococcal septic shock with
associated acute respiratory distress syndrome andmultisystem organ failure inwhich the patient made
a full clinical recovery this is also the ﬁrst case of gonococcal septic shock treated with activated protein
C; an association between its use and the favorable outcome is postulated, but cannot be conﬁrmed.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Gonorrhea is a sexually transmitted infection caused by the
bacterium Neisseria gonorrhoeae. Gonococcal infection is both
preventable and treatable, but despite this remains a cause of
signiﬁcant morbidity including pelvic inﬂammatory disease,
epididymitis, and infertility. Rarely, disseminated infection may
result in sepsis or septic shock, with poor prognoses based on
previous literature.
Case report
A 36-year-old previously healthy Aboriginal woman with a
history of alcohol use was brought to a remote healthcare center
in the Canadian North with a several day history of
progressive confusion and a 3-week history of lower abdominal
pain. On arrival she was hypotensive with a blood pressure of 60/
42 mmHg, tachycardic, and oliguric. Glasgow coma score (GCS)
was 5, temperature 38.1 8C, respiratory rate 30–35 breaths/min,
and oxygen saturation by pulse oximetry was 98% on 4 l by nasal
cannulae. She was ﬂuid resuscitated, supported with vasopres-* Corresponding author. Tel.: +1 780 407 6755; fax: +1 780 407 1228.
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doi:10.1016/j.ijid.2009.08.021sors, and intubated. Due to the challenges of arctic winter and
distance (over 2000 km) transfer to our tertiary care center
required13 h. Physical examination at theperipheral hospitalwas
non-contributory.
Limited laboratory investigations prior to transfer included:
hemoglobin 105 g/l; leukocyte count 11.9  109/l (86% neutro-
phils, no left shift); platelet count 137  109/l; creatinine
279mmol/l (previously documented to be normal); international
normalized ratio (INR) 1.7. An arterial blood gas revealed a severe
metabolic acidosis with an anion gap of 16. Osmolality and toxic
alcohol testing were not available. An ethanol infusion was
initiated for possible toxic alcohol ingestion. Empiric ceftriaxone
and vancomycinwere administered after obtaining blood cultures.
Upon arrival at our intensive care unit (ICU), the patient was
comatose and hemodynamically unstable requiring high dose
vasopressor support. Urine output improved with ﬂuid resuscita-
tion and an increase in mean arterial pressure – dialysis was not
required. The serum osmolal gap was normal; additionally,
methanol, ethylene glycol, and isopropanol levels were undetect-
able. The ethanol infusion was thus discontinued. The patient
remained on empiric broad-spectrum antimicrobials and vaso-
pressors for septic shock. Adjunctive corticosteroids were pre-
scribed for vasopressor-dependent septic shock.1 Admission blood
work revealed: leukocyte count 33.4  109/l with 24% bands;
platelets 111  109/l; creatinine 270mmol/l; lactate 6.1 mmol/l;ses. Published by Elsevier Ltd. All rights reserved.
Figure 1. Multiple left hand purpuric lesions.
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aminotransferase (ALT) 5864 U/l, alkaline phosphatase (ALP)
254 U/l, bilirubin 64 mmol/l). Additional laboratory results were
not consistent with disseminated intravascular coagulation.
Random cortisol was 962 nmol/l. The acute physiology and chronic
health evaluation (APACHE) II score calculatedwithin the ﬁrst 24 h
of admission was 30, with a predicted mortality of 70.3%.
Chest radiography demonstrated bilateral patchy alveolar
airspace disease with a PaO2/FiO2 ratio of 125 and no evidence of
left atrialhypertensionbasedoncentral venouspressuremonitoring
and 2D-echocardiography. An electrocardiogram demonstrated
sinus tachycardia. Initial central venous oxygen saturation was
57%, which improved with inotropic support. An ultrasound of the
abdomen demonstrated fatty inﬁltration of the liver.
On the second day of admission, the peripheral microbiology
laboratory reported Gram-negative diplococci from initial blood
cultures. The evolving physical examination demonstrated previ-
ously undocumented conjunctival suffusion, bilateral knee effu-
sions, and multiple purpuric lesions on the palms, ﬁngers, shins,
and soles of the feet (Figure 1). A pustular lesion was noted on the
right lateral thigh (Figure 2). Meningismus was not present.
Meningococcemia was suspected and treatment with activated
protein C (APC) was initiated after completion of a lumbar
puncture 33 h from the time of ICU admission. Cerebrospinal ﬂuid
(CSF) parameters werewithin normal limits, includingwhite blood
cell count, protein, glucose, and Gram stain. On the third day of
admission however, Neisseria gonorrhoeae was conﬁrmed as the
blood culture isolate. The isolate was susceptible to ceftriaxoneFigure 2. Pustular lesion noted on the right lateral thigh.and ciproﬂoxacin. Given this result, the patient’s history of
abdominal pain was assumed to be due to pelvic inﬂammatory
disease (PID). A limited gynecological examination was normal.
Left knee arthrocentesis did not reveal an inﬂammatory or
septic arthritis. A vaginal specimenwas negative forN. gonorrhoeae
and Chlamydia trachomatis by nucleic acid testing (NAT). A vaginal
specimen was obtained due to ease of collection and similar
sensitivity and speciﬁcity for this collection site.2,3 Pregnancy
testing and serology for HIV, syphilis, and hepatitis B were
negative. Hepatitis C serology was positive. A transesophageal
echocardiogram demonstrated a hyperdynamic left ventricle
consistent with distributive shock. Valvular vegetations were
not present. Complement levels were globally reduced: C3 0.54 g/l
(normal range 0.80–2.00), C4 0.07 g/l (normal range 0.18–0.36),
and total hemolytic complement (CH50) <10 kU/l (normal range
22–60). Quantitative immunoglobulins were normal.
The patient gradually improved with mechanical ventilation,
vasopressor support, antimicrobials, corticosteroids, APC, and
supportive ICU care. Pulmonary, renal, hepatic and cerebral
function improved and she was extubated on the twelfth day of
hospitalization. She was transferred to the general internal
medicine ward two days later and eventually to her home
community, with complete recovery of all organ systems. She
completed 10 days of intravenous ceftriaxone. On later question-
ing, the patient denied any symptoms of PID other than lower
abdominal pain. A full gynecological examination was to be
completed as an outpatient.
Public health was notiﬁed and the patient’s common-law
husband was provided with testing and follow-up.
Discussion
We have no doubt that gonococcal sepsis and septic shock are
more common than reﬂected in the existing literature; epidemio-
logic descriptions of this condition are sorely lacking.
We could identify only two previously published case reports of
gonococcal septic shock, both of which were fatal.4,5 The ﬁrst case,
described in 1980, involved a 19-year-old male with Hodgkin’s
disease who underwent splenectomy and radiation therapy. He
developed fulminantgonococcemia12months laterassociatedwith
a petechial rash, and died within 18 h of hospital admission. The
second case, reported in 2001, was a 53-year-old woman found
unconscious in her apartment with a history of heavy alcohol use,
liver cirrhosis, and severemalnutrition. Thediagnosis and treatment
of gonococcemia were delayed, likely contributing to her poor
outcome. The patient required mechanical ventilation, and devel-
oped multisystem organ failure and refractory shock prior to her
death.N. gonorrhoeaewas isolated fromblood cultures inboth cases,
as in our patient. Reasons for our patient’s favorable outcome in
comparison to these two fatal cases can only be postulated; immune
competence, relatively early diagnosis and treatment, and the use of
APC may all have been contributing factors.
Gonococcal sepsis with acute adult respiratory distress
syndrome (ARDS) has likewise rarely been reported in the
literature. The ﬁrst two cases, reported in 1976 and 1980, describe
immunocompetent patients with gonococcal sepsis who devel-
oped hypoxia and acute bilateral pulmonary inﬁltrates.6,7 Both
patients improved with antimicrobials and one patient received
high-dose corticosteroid therapy. Neither of the patients required
mechanical ventilation and both made a full recovery. The third
reported case in 1991 was the ﬁrst case to require mechanical
ventilation.8 Measurements of wedge pressure were obtained by
pulmonary artery catheterization to rule out cardiac dysfunction.
The patient eventually made a full recovery. Our patient, therefore,
would be the second reported case of gonococcal sepsis and ARDS
requiring mechanical ventilation.
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infection,9–11 resulting in a prothrombotic state. Microvascular
thrombosis is thought to contribute to multisystem organ failure.
APC has proﬁbrinolytic, antithrombotic, and anti-inﬂammatory
properties – resulting in decreased microvascular thrombosis and
improved end-organ function. Although somewhat controver-
sial,12 its use has been shown to decrease morbidity and mortality
in patients with septic shock, including those with meningococ-
cemia and particularly those with purpura fulminans.13–16
Neisseria meningitidis and N. gonorrhoeae share multiple virulence
factors and presumably common pathophysiology in human
infection. Lipooligosaccharide endotoxemia causes the release of
inﬂammatory cytokines such as interleukin (IL)-1, IL-6, tumor
necrosis factor (TNF), and interferon (IFN)-g.17–19 Given this
common pathophysiology, APC may also be beneﬁcial in the
treatment of gonococcal sepsis, and might have contributed to our
patient’s favorable outcome.
Deﬁciencies of both early and terminal components of the
complement cascade have been associated with increased
susceptibility to neisserial infection.20–24 Complement deﬁciency
may also result from complement activation in sepsis. We suspect
our patient’s complement levels weremarkedly reduced as a result
of sepsis and not due to a preexisting deﬁciency, however follow-
up testing will be pursued.
In summary, gonococcal septic shock has rarely been reported,
andbothpreviously reportedcases resulted in fataloutcomes.This is
in contrast to the full recovery observed in the current case despite
ARDS and multisystem organ dysfunction. Early diagnosis, young
patient age, immune competence, and aggressive sepsis manage-
ment may have contributed to our patient’s favorable outcome.
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